MNG-03 PD-L1 EXPRESSION, PATIENT PROGNOSIS AND INITIAL WHO GRADE IN GRADE II/III MENINGIOMA

von Kamamoto, Dai, Sasaki, Hikaru, Sasao, Ryota, Fujiyama, Takumi, Yoshida, Kazunari
Veröffentlicht in Neurooncol Adv (2019)

PEDT-02 Clinical usage of NCC Oncopanel/FoundationOne CDx for pediatric/AYA patients with recurrent malignant brain tumors

von Shibahara, Ichiyo, Kumabe, Toshihiro, Hide, Takuichiro, Sasao, Ryota, Sasaki, Hikaru, Sasaki, Jiichiro
Veröffentlicht in Neurooncol Adv (2020)